Rheumatology
Rheumatology

 

Pediatric Rheumatology

 

The Division of Rheumatology at Children's Mercy Kansas City provides expertise in the evaluation and treatment of a wide range of rheumatic, autoimmune, and musculoskeletal diseases in children.

Rheumatology Staff

Our multidisciplinary team understands the complex physical and emotional needs of a child with a chronic illness. Our team consists of board-certified pediatric rheumatologists, clinic nurses, a nurse manager, a care assistant, an on-site social worker, and research coordinators. We maintain strong relationships with occupational and physical therapists to optimize the therapeutic options we have for our families. 

Expanding Services

A new pain management program is also being created to provide comprehensive, multidisciplinary treatment for patients with chronic pain.

Current Research Areas

  • Predicting Response of Methotrexate Treatment (PROMOTE):  A signature for response to Methotrexate to find out if we can predict who will respond to Methotrexate and who will not.
  • Childhood Arthritis & Rheumatology Research registry: a national registry to collect information on children with rheumatic diseases.
  • JARS: This study is a biorepository of synovial fluid from inflamed joints that are undergoing arthrocentesis and intra-articular steroid injection for routine clinical care.
  • PRCOIN: PR-COIN is a multi-site learning network created to improve the process and outcomes of care delivery for children with juvenile idiopathic arthritis.
  • Folate and Arthritis Screening in Down syndrome: We hope to understand the need for folate and other nutrient supplementation and the risk associated with folate interrupting medications such as methotrexate. Also to prospectively screen for under recognized signs of arthritis in this vulnerable population.
  • A randomized, double-blind, placebo-controlled, multicenter, phase 3 efficacy and safety study of 2 dose levels of subcutaneous Anakinra (Kineret®) in patients with Still’s Disease, (SJIA and AOSD):  Evaluating the efficacy and safety of Anakinra to treat systemic juvenile arthritis and adult onset Still’s Disease.

Copyright © 2018 The Children’s Mercy Hospital